Umedic Group Bhd's revenue for the
three
months ended in Jan. 2025 was RM11.58 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jan. 2025 was RM51.20 Mil.
Umedic Group Bhd's Revenue per Share for the
three
months ended in Jan. 2025 was RM0.03.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2025 was RM0.14.
Warning Sign:
Umedic Group Bhd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Umedic Group Bhd was 3.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 17.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 28.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 6 years, Umedic Group Bhd's highest 3-Year average Revenue per Share Growth Rate was 70.00% per year. The lowest was 17.10% per year. And the median was 24.60% per year.
Umedic Group Bhd Revenue Historical Data
The historical data trend for Umedic Group Bhd's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Umedic Group Bhd's Revenue
For the Medical Devices subindustry, Umedic Group Bhd's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Umedic Group Bhd's Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Umedic Group Bhd's Revenue distribution charts can be found below:
* The bar in red indicates where Umedic Group Bhd's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was RM51.20 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Umedic Group Bhd (XKLS:0256) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Umedic Group Bhd Revenue Related Terms
Thank you for viewing the detailed overview of Umedic Group Bhd's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Umedic Group Bhd is principally involved in the marketing and distribution of various branded medical devices and consumables as well as the provision of after-sales service for all products. The company is also involved in developing, manufacturing, and marketing of medical consumables. It has two reportable segments: marketing and distribution, which includes marketing and distribution of medical devices and the provision of after-sales service; the manufacturing segment includes developing, manufacturing, and marketing of medical devices. The company generates the majority of its revenue from the marketing and distribution segment. The company has customers in Asia Pacific, Americas, Europe, Middle East, Africa, and Oceania geographically.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKLS:0256 has been successfully added to your 